MedTrace Logo

Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease

NCT05212766 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2023-10-10

No results posted yet for this study

Summary

Determining whether in the mouth there are differences between the participant groups in the nature and activity of mucosal innate immunity, in immune responses to SARS-COV2 antigens, or in the oral microbiome

Conditions

  • COVID-19
  • Microbial Colonization
  • Oral Disease
  • Periodontal Diseases
  • Innate Inflammatory Response
  • Mucosal Infection

Interventions

BIOLOGICAL

COVID infection

Infections with COVID 19

BIOLOGICAL

COVID vaccination

Vaccination against COVID 19

DIAGNOSTIC_TEST

Oral examination

Assessment of oral and periodontal health status

Sponsors & Collaborators

  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER

  • UK Research and Innovation

    collaborator OTHER

  • King's College London

    lead OTHER

Principal Investigators

  • Stephen J Challacombe, PhD · King's College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-07
Primary Completion
2023-10-30
Completion
2024-12-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05212766 on ClinicalTrials.gov